8 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 8 of 8 clinical reviews.
Evidence-based adverse-event management protocols for BPC-157 and TB-500 healing peptides, including grading scales, clinical decision points, dose modifications, and when to discontinue therapy.
A prescriber-level monograph covering the pharmacology, mechanisms, dosing protocols, safety data, and regulatory status of healing peptides BPC-157 and TB-500 (thymosin beta-4). Includes inline citations to primary research.
Clinician-focused drug-drug interaction reference for BPC-157 and TB-500 healing peptides, covering known pharmacologic interactions, CYP considerations, and co-prescribing precautions.
Evidence-based monitoring protocol for BPC-157 and TB-500 peptide therapy. Lab panels, timing, safety signals, and clinical decision points for prescribers managing tissue-repair peptides.
A prescriber-level guide to BPC-157 and TB-500 dosing, titration schedules, tapering protocols, and the clinical rationale behind each step, with primary-source citations throughout.
Evidence-based special-populations guide for BPC-157 and TB-500 (thymosin beta-4). Covers renal impairment, hepatic dysfunction, pediatrics, geriatrics, pregnancy, lactation, and immunocompromised patients at MD/PharmD level.
A prescriber-level comparison of BPC-157 and TB-500 (thymosin beta-4), covering mechanisms, tissue targets, dosing protocols, stacking rationale, and the clinical evidence base for each healing peptide class.
A prescriber-level guide to billing, coding, prior authorization, and regulatory compliance for BPC-157 and TB-500 healing peptides, including compounding pharmacy workflows and cash-pay models.